High Resolution, High-speed Multimodal Ophthalmic Imaging

Launched by CENTRE HOSPITALIER NATIONAL D'OPHTALMOLOGIE DES QUINZE-VINGTS · Oct 14, 2019

Keywords

ClinConnect Summary

This clinical trial is exploring a new high-resolution and high-speed imaging system designed to take detailed pictures of the eye. It aims to improve our understanding of various eye conditions that can lead to blindness, such as retinitis pigmentosa, glaucoma, and macular degeneration. By using advanced technology, the study hopes to visualize tiny structures in the eye that current imaging methods cannot see, and to measure important functions like blood flow speed. This could greatly enhance how we monitor and treat eye diseases.

To participate in the trial, you need to be at least 18 years old and either have an eye condition or be a healthy volunteer. You will need to agree to participate by signing a consent form and be covered by health insurance. However, certain individuals, such as those with specific medical devices, infections, or who are pregnant, may not be eligible. If you join the study, you can expect to undergo eye imaging using the new technology, which could provide valuable information for your eye health or for research purposes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • People over 18
• • Patient with a pathology affecting the eye or healthy volunteer
• • Participant who signed the consent
• • Beneficiaries of the health insurance
• Exclusion Criteria:
• • Patients with a history of photosensitivity.
• • Patients who have just received a photodynamic therapy treatment (
• • Patients taking drugs with photosensitivity as a side effect.
• • Persons with pacemakers or other implanted electronic medical device
• • Patients with viral conjunctivitis or any other infectious disease.
• • Patients with skin lesions on the neck or forehead
• • Patients at high risk of damage from optical radiation, such as aphakic patients, or patients with decreased sensitivity to light due to fundus disease.
• • Pregnant or lactating women
• • Participant unable to be followed throughout the study
• • Vulnerable people
• • Subjects with predisposition to closure of the iridocorneal angle